Transcriptional Plasticity Drives Leukemia Immune Escape.
Journal
Blood cancer discovery
ISSN: 2643-3249
Titre abrégé: Blood Cancer Discov
Pays: United States
ID NLM: 101764786
Informations de publication
Date de publication:
06 09 2022
06 09 2022
Historique:
received:
10
11
2021
revised:
21
04
2022
accepted:
08
06
2022
pubmed:
17
6
2022
medline:
9
9
2022
entrez:
16
6
2022
Statut:
ppublish
Résumé
Relapse of acute myeloid leukemia (AML) after allogeneic bone marrow transplantation has been linked to immune evasion due to reduced expression of major histocompatibility complex class II (MHCII) genes through unknown mechanisms. In this work, we developed CORENODE, a computational algorithm for genome-wide transcription network decomposition that identified a transcription factor (TF) tetrad consisting of IRF8, MYB, MEF2C, and MEIS1, regulating MHCII expression in AML cells. We show that reduced MHCII expression at relapse is transcriptionally driven by combinatorial changes in the expression of these TFs, where MYB and IRF8 play major opposing roles, acting independently of the IFNγ/CIITA pathway. Beyond the MHCII genes, MYB and IRF8 antagonistically regulate a broad genetic program responsible for cytokine signaling and T-cell stimulation that displays reduced expression at relapse. A small number of cells with altered TF abundance and silenced MHCII expression are present at the time of initial leukemia diagnosis, likely contributing to eventual relapse. Our findings point to an adaptive transcriptional mechanism of AML evolution after allogeneic transplantation whereby combinatorial fluctuations of TF expression under immune pressure result in the selection of cells with a silenced T-cell stimulation program. This article is highlighted in the In This Issue feature, p. 369.
Identifiants
pubmed: 35709529
pii: 704883
doi: 10.1158/2643-3230.BCD-21-0207
pmc: PMC9897290
doi:
Substances chimiques
Histocompatibility Antigens Class II
0
Interferon Regulatory Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
394-409Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL155144
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA136432
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL069142
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA206963
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA210030
Pays : United States
Informations de copyright
©2022 The Authors; Published by the American Association for Cancer Research.
Références
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Genome Biol. 2014;15(12):550
pubmed: 25516281
Blood. 2013 Mar 7;121(10):1839-49
pubmed: 23319570
Immunity. 2005 Sep;23(3):275-86
pubmed: 16169500
Int J Hematol. 2015 Apr;101(4):342-51
pubmed: 25749660
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Nat Genet. 2018 Sep;50(9):1240-1246
pubmed: 30127528
J Exp Med. 2019 May 6;216(5):1071-1090
pubmed: 30948495
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Curr Opin Hematol. 2016 Jul;23(4):354-61
pubmed: 27258906
N Engl J Med. 2018 Dec 13;379(24):2330-2341
pubmed: 30380364
Science. 2009 Jul 24;325(5939):429-32
pubmed: 19628860
Leukemia. 2015 Jan;29(1):157-68
pubmed: 24957708
Nat Rev Drug Discov. 2021 Sep;20(9):669-688
pubmed: 34006959
Leukemia. 2018 Apr;32(4):882-889
pubmed: 29089643
Nat Med. 2019 Apr;25(4):603-611
pubmed: 30911134
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Nat Rev Cancer. 2008 Jul;8(7):523-34
pubmed: 18574464
Cancer Discov. 2022 Jun 2;12(6):1449-1461
pubmed: 35255120
Nat Genet. 2016 Oct;48(10):1193-203
pubmed: 27526324
Nat Rev Immunol. 2005 Oct;5(10):793-806
pubmed: 16200082
Genes Dev. 2022 Mar 1;36(5-6):368-389
pubmed: 35301220
Blood Cancer Discov. 2022 Jan;3(1):32-49
pubmed: 35019859
Cancer Cell. 2013 Dec 9;24(6):777-90
pubmed: 24332044
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Curr Opin Genet Dev. 2016 Apr;37:101-108
pubmed: 26950762
Cancer Discov. 2017 Oct;7(10):1136-1153
pubmed: 28729405
Bone Marrow Transplant. 1997 May;19(10):989-99
pubmed: 9169643
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Front Oncol. 2019 Nov 19;9:1217
pubmed: 31803612
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cell. 2017 Jul 27;170(3):577-592.e10
pubmed: 28753431
Blood. 2008 May 1;111(9):4532-41
pubmed: 18326819
Genome Res. 2016 Mar;26(3):385-96
pubmed: 26843070
Mol Cell. 2001 Jan;7(1):105-15
pubmed: 11172716
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Front Immunol. 2019 Aug 13;10:1907
pubmed: 31456804
J Clin Invest. 2020 Dec 1;130(12):6677-6687
pubmed: 32897878
Nat Rev Cancer. 2020 Mar;20(3):158-173
pubmed: 31907378
Trends Immunol. 2006 Sep;27(9):405-12
pubmed: 16870508
Nucleic Acids Res. 2015 Mar 31;43(6):3128-42
pubmed: 25753668
PLoS One. 2016 Nov 22;11(11):e0166438
pubmed: 27875550
PLoS Genet. 2011 Jun;7(6):e1002097
pubmed: 21731497
Science. 2018 May 18;360(6390):800-805
pubmed: 29622725